Dimissione e periodo vulnerabile: come evitare le reospedalizzazioni precoci.

Similar documents
Preventing Heart Failure Readmissions by Using a Risk Stratification Tool

Heart Failure Order Sets. Standardizing Care for the Heart Failure Patient 2012

The Effect of an Interprofessional Heart Failure Education Program on Hospital Readmissions

Challenging The 2015 PH Guidelines - comments from the Nurses. Wendy Gin-Sing RN MSc Pulmonary Hypertension CNS Imperial College Healthcare NHS Trust

University Cincinnati Medical Center

Presenter Disclosure Information

From Risk Scores to Impactability Scores:

A Virtual Ward to prevent readmissions after hospital discharge

Patient Interview/Readmission Chart Review. Hospital Review:

Using Facets of Midas+ Hospital Case Management to Support Transitions of Care. Barbara Craig, Midas+ SaaS Advisor

Coordinated Outreach Achieving Community Health (COACH) for Heart Failure Learning Objectives

Providing and Billing Medicare for Transitional Care Management

Brittany Turner, 2015 PharmD Candidate 1 Justin Campbell, PharmD 2 Katie McKinney, PharmD, MS, BCPS 2

Bridging the Gap: Discharge Clinics Providing Safe Transitions for High Risk Patients

New pharmacy practice opportunity: Enhancement of the transitions of care process

Decreasing the Unplanned Readmission Rate of Patients receiving Outpatient Antibiotic Therapy(OPAT)

PACT AS A READMISSION REDUCTION STRATEGY KAISER PERMANENTE - COLORADO REGION

Improving Transitions of Care

What is Transition of Care?

Payer s Perspective on Clinical Pathways and Value-based Care

Presenter Disclosure

Chronic Care Taking Disease Management Beyond Hospital Walls

Heart Failure Nurse Practitioner Role Development and Proposal. Anita M. Wilson, BSN, RN. ACNP, DNP Student Creighton University

Presenter Disclosure

10/27/10. Michelle Mourad MD Arpana Vidyarthi Ellen Kynoch. pulmonary edema. sodium intake & daily weights

The BOOST California Collaborative

Transitions in Care. Why They Are Important and How to Improve Them. U. Ohuabunwa MD

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine

Project BOOST Be'er Outcomes by Op2mizing Safe Transi2ons

SO YOU WANT TO IMPROVE THE DISCHARGE PROCESS?

2) The percentage of discharges for which the patient received follow-up within 7 days after

Objectives. Prevalence of Non-Adherence. Medications and Care Transitions. The Cost of Readmissions. The Pharmacist s Role in Improving Care 4/22/2015

Transitional Care Management JANET BEASY, CPC, CPCO, CMC, CMOM PRACTICE EDUCATION CONSULTANT

Patient Activation Using Technology- Supported Navigators

Models of community heart failure care pathways. Dr Jim Moore GP & GPSI Cardiology Cheltenham,GLOS

A Regional Payer/Provider Partnership to Reduce Readmissions The Bronx Collaborative Care Transitions Program: Outcomes and Lessons Learned

INTERMACS has a Key Role in Reporting on Quality Metrics

Transitions of Care: From Hospital to Home

Improving Care Transitions

Deborah Perian, RN MHA CPHQ. Reduce Unplanned Hospital Admissions: Focus on Patient Safety

Home Assessments Resulting in a Positive Effect on Outcome Score Cards

Transitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose.

Chronic Disease Management Resources & Services

H2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome

MediServe. More than 25 Years Serving the Rehab and Respiratory Communities

Causes and Consequences of Regional Variations in Health Care Resources in Ontario

REDUCING READMISSIONS through TRANSITIONS IN CARE

Baystate Medical Center

Caring for Patients with Advanced and Serious Illnesses: Changing Medical Practice and Patient Expectations. Aetna s Compassionate Care SM Program

Transitions of Care from a Community Perspective

STRATEGIES AND SOLUTIONS FOR REDUCING INAPPROPRIATE READMISSIONS

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form

The Community Care Navigator Program At Lawrence Memorial Hospital

Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy

Transitions of Care Innovations in the Medical Practice Setting

CV SURGERY 30 DAY RE-ADMISSION. CMS IS WATCHING YOU, AND YOU, AND ME TOO.

Embedded Case Manager

Medication Challenges in Care Transitions: Issues Faced by Patients, Providers & Community Professionals

CHF Readmission Initiative. Mary Fischer MSN, CCRN, PCCN, CHFN Cardiology Clinical Nurse Specialist St. Vincent Hospital Indianapolis, Indiana

Transitions of Care. ACOI Clinical Challenges in Inpatient Care. March 31, 2016 John B. Bulger, DO, MBA

Transition hôpital-domicile: Risques et opportunités! Pr Martine LOUIS SIMONET Formation Continue Médecins de Famille Genève 14 avril 2016

Improving Transitions to Home & Community- Based Care Settings

New Quality Measures Will Soon Impact Nursing Home Compare and the 5-Star Rating System: What providers need to know

Reducing Readmissions One-caseat-a-time Using Midas+ Community Case Management

Clinical Webinar: Integrated Pharmacy

Objectives 9/18/2018. Patient Driven Payment Model(PDPM) Janine Finck Boyle, MBA/HCA, LNHA Vice President of Regulatory Affairs Fall 2018

Redesigning Post-Acute Care: Value Based Payment Models

Breaking Down Silos of Care: Integration of Social Support Services with Health Care Delivery

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Continuing Education Disclosures

January 4, Via Electronic Mail to file code CMS-3317-P

An Integrated Approach to Heart Failure Care. Paul C. Freiman, MD, FACC and Donna A. Smith, RN, BSN

Leveraging Your Facility s 5 Star Analysis to Improve Quality

Heart Failure Clinic a Multidisciplinary approach. Amy Benson, PA-C, MSPAS Presbyterian Heart Group Albuquerque, NM

AN OVERVIEW of TARGET HF: QUALIFYING for the HONOR ROLL and a DETAILED FOCUS on MEDICATION COMPLIANCE (ACE/ARB, ADLOSTERONE ANTAGONIST, and EBBB)

Connect HF Solution. Case Study. Reducing 30-Day Heart Failure. How Process Optimization and Peer-to-Peer Connections Standardized HF Care

Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives

Best Practices in Managing Patients with Heart Failure Collaborative

2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY

Hamilton Health Sciences STRATEGIC PLAN. Patients PLAN AT A GLANCE People. Sustainability. Research, Innovation & Learning

Karen Stasium, BS, MPT, COS C, HCS D

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 537 of 593

IHI Expedition. Reducing Readmissions by Improving Care Transitions Session 2. Expedition Coordinator

Improving Patient Safety Across Michigan and Illinois

Reducing Readmissions: Potential Measurements

Presenter Disclosure Information

Objectives. Integrating Palliative Care Principles into Critical Care Nursing

PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management

Use of Health Information Technology to Reduce Health Risk

Admissions, Readmissions & Transitions Core Functions & Recommended Actions

Cost-Effective Management of a High- Risk Population Using Analytics: Care Processes That Make A Difference for Patients With Heart Failure

CAHPS Focus on Improvement The Changing Landscape of Health Care. Ann H. Corba Patient Experience Advisor Press Ganey Associates

Care Transitions in Behavioral Health

PPS Performance and Outcome Measures: Additional Resources

Transitional Care Management. Marianne Durling, MHA, RHIA, CCS,CDIP, CPC,CPCO,CIC & Heather Greene, MBA, RHIA, CPC, CPMA

Pharmacists in Transitions of Care: We Can All Make a Difference

Coding and Reimbursement Tip Sheet for Transition from Pediatric to Adult Health Care

Kentucky Stroke Transitions Assistance Resource

MEDICARE COMPREHENSIVE CARE FOR JOINT REPLACEMENT MODEL (CCJR) Preparing for Risk-Based Outcomes of Bundled Care 8/12/2015.

2017 Congestive Heart Failure. Program Evaluation. Our mission is to improve the health and quality of life of our members

Transcription:

Scompenso Cardiaco Acuto Convention Centri Scompenso Dimissione e periodo vulnerabile: come evitare le reospedalizzazioni precoci. G. Di Tano Cardiologia, Cremona

Early Re-hospitalizations 30 days OHF - Chronic HF De novo HF Worsening HF ED Hospital Admission for AHF Early and Later Post-discharge period OHF - Chronic HF In-hospital Mortality Early Mortality The steps of Heart Failure patient s journey DT14

Rehospitalization is high in the early and later phase after hospitalization 30 days from discharge 1 patient out of 4 is readmitted

Progetto re-ospedalizzazioni precoci Area Scompenso 2012-2014 The 30-day metric in Acute Heart Failure revisited. Data from IN-HF Outcome, an Italian Nationwide Cardiology Registry 1855 AHF enrolled 118 (6.4%) died in-hospital 159 transferred to other hospital 57 discharged to skilled nursing facilities 1 lost 1520 Discharged home 94 readmitted (6.1%) - 91% for CV causes - 42 dead (2.8%) 0 At 30 days from discharge 126 overall dead or readmitted (8.3%) At 30 days from 0 admission 7.6% dead G. Di Tano, R. De Maria et al. EJHF submitted

IN-HF 30 day outcome in 1520 discharged home 30-d read-free survivors 30-d readmitted or dead

Logistic regression independent predictors of death+ readmission or readmission at 30 days Combined death+read p 0R 95% Days Length of stay 0.0016 1.023 1.008 1.037 Worsening HF vs de novo 0.0045 1.828 1.206 2.772 Inotropes 0.0006 2.189 1.398 3.426 ACE/ARBs at discharge 0.0012 0.522 0.352 0.774 C statistic 0.695 Days Length of stay 0.0076 1.020 1.005 1.034 Worsening HF vs de novo 0.0079 1.909 1.185 3.076 ACE/ARBs at discharge 0.0013 0.486 0.313 0.754 C statistic 0.662 Il pz che muore/rericovera nelle Cardiologie a breve, ha SC cronico avanzato, disf renale, degenza lunga, con inotropi, meno RAS-inib.

Predictors of 30-Day Readmission in 412 Pts Hospitalized With Decompensated Heart Failure ( Hernadez MB et al, Clin. Cardiol. 2013 )

TROPONIN, injury, cardiovascular events AST/ALT, organ damage

IN HOSPITAL Early HF readmission and 30-day mortality are associated with the process of inpatient care Meta-analysis of 13 studies: The risk of early readmission is increased by 55% when inpatient care is of relatively low quality... I was discharged early! They told me to just take these tablets!!! Ashton CM et al. Ann Intern Med. 2005;122:415. Ashton CM et al. Med Care. 2007;35:1044

Valle R et al

Discharge and Follow-up: The beginning of the journey of a vulnerable patient For many if not most patients, hospitalization is just one step in chronic Heart Failure Once acute decompensation is stabilized we move quikly to optimize chronic therapy IN HOSPITAL to prevent rehospitalization. PRE-DISCHARGE therapy determines early outcome

2001

Hospital Discharge Recommendation or Indication COR LOE Performance improvement systems in the hospital and early postdischarge outpatient setting to identify HF for GDMT I B Before hospital discharge, at the first postdischarge visit, and in subsequent follow-up visits, the following should be addressed: a) initiation of GDMT if not done or contraindicated; b) causes of HF, barriers to care, and limitations in support; c) assessment of volume status and blood pressure with adjustment of HF therapy; d) optimization of chronic oral HF therapy; e) renal function and electrolytes; f) management of comorbid conditions; g) HF education, self-care, emergency plans, and adherence; and h) palliative or hospice care. I B Multidisciplinary HF disease-management programs for patients at high risk for hospital readmission are recommended A follow-up visit within 7 to 14 days and/or a telephone follow-up within 3 days of hospital discharge is reasonable Use of clinical risk-prediction tools and/or biomarkers to identify higher-risk patients is reasonable I IIa IIa B B B

Patient Care Plan Date of discharge Name and contact information for physician and DA Medications Pending tests and results Follow-up appointments Calendar Other orders (diet, activity, etc.) Information about disease or condition When to call physician or seek emergency care Form for writing down questions Map for locating appointments (optional) Other information about your center (optional)

(52% of HF patients are not seen in the first 30 days after a hospitalization... Jencks et al. N Engl J Med 2009 )

First post-discharge assessment When?

For a patient hospitalized due to AHF, pre-discharge phase is crucial for the optimal preparation to the vulnerable period of transition from in-patient to out-patient care. During this phase the following aspects should be addressed: Disease-modifying therapies should be initiated before discharge and carefully optimized during early post-discharge period. Comorbid conditions detected and managed. Patients at the highest risk identified and carefully followed. Potential precipitant causes of recurrent HF characterised. Patients enrolled in the multi-faced disease management projects.

Circ Cardiovasc Qual Outcomes. 2013 1) Partnering with community physicians or physician groups to reduce readmission (0.33 percentage point lower RSRRs; P=0.017) 1) Partnering with local hospitals to reduce readmissions (0.34 percentage point; P=0.020) 2) Having nurses responsible for medication reconciliation (0.18 percentage point; P=0.002) 3) Arranging a follow-up appointment before discharge (0.19 percentage point; P=0.037) 4) Having a process in place to send all discharge paper or electronic summaries directly to the patient s primary physician (0.21 percentage point; P=0.004), 5) Assigning staff to follow up on test results that return after the patient is discharged (0.26 percentage point; P=0.049)

Un MINIMAL DATA SET alla dimissione per il Medico di Famiglia

FOLLOW-UP DOPO LA DIMISSIONE OSPEDALIERA PZ A BASSO PROFILO DI RISCHIO Follow-up di 1-(3)-6 mesi presso l ambulatorio Scompenso Cardiaco per up-tritation della terapia, FU strumentale, valutazione devices, PZ AD ALTO PROFILO DI RISCHIO Decorso osp. BNP no - Re-ammissione - compliance Disf. Renale Comorbidità +++ Score +++ Visita precoce (< 7 gg) presso l Ambulatorio Scompenso Cardiaco Protocolli Terapeutici ambulatoriali Pz stabile Pz instabile Stretto monitoraggio telefonico domiciliare Reinvio e coinvolgimento del MMG - Follow-up telefonico Prosecuzione del Follow-up (tempi succ visita variabili ) ambulatoriale e telefonico

N Engl J Med 370;8, 2014